European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
Top Cited Papers
Open Access
- 29 March 2011
- journal article
- practice guideline
- Published by Springer Science and Business Media LLC in European Child & Adolescent Psychiatry
- Vol. 20 (4), 173-196
- https://doi.org/10.1007/s00787-011-0163-7
Abstract
To develop a European guideline on pharmacologic treatment of Tourette syndrome (TS) the available literature was thoroughly screened and extensively discussed by a working group of the European Society for the Study of Tourette syndrome (ESSTS). Although there are many more studies on pharmacotherapy of TS than on behavioral treatment options, only a limited number of studies meets rigorous quality criteria. Therefore, we have devised a two-stage approach. First, we present the highest level of evidence by reporting the findings of existing Cochrane reviews in this field. Subsequently, we provide the first comprehensive overview of all reports on pharmacological treatment options for TS through a MEDLINE, PubMed, and EMBASE search for all studies that document the effect of pharmacological treatment of TS and other tic disorders between 1970 and November 2010. We present a summary of the current consensus on pharmacological treatment options for TS in Europe to guide the clinician in daily practice. This summary is, however, rather a status quo of a clinically helpful but merely low evidence guideline, mainly driven by expert experience and opinion, since rigorous experimental studies are scarce.Keywords
This publication has 273 references indexed in Scilit:
- Short-term Sulpiride Treatment of Children and Adolescents With Tourette Syndrome or Chronic Tic DisorderJournal of the Formosan Medical Association, 2009
- Color perception deficits in co-existing attention-deficit/hyperactivity disorder and chronic tic disordersJournal of Neural Transmission, 2007
- Co-existence of tic disorders and attention-deficit/hyperactivity disorder-recent advances in understanding and treatmentEuropean Child & Adolescent Psychiatry, 2007
- Stress fracture of the peroneal bone secondary to a complex ticBrain & Development, 2006
- Non?stimulant medications in the treatment of ADHDEuropean Child & Adolescent Psychiatry, 2004
- Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndromeMovement Disorders, 1996
- Differential responsiveness to lithium in patients with Tourette disorderNeuroscience & Biobehavioral Reviews, 1989
- The effects of naloxone in tourette's syndromeAnnals of Neurology, 1985
- Tardive dyskinesia in Tourette syndromePediatric Neurology, 1985
- Physostigmine in Gilles de la Tourette's SyndromeThe New England Journal of Medicine, 1980